| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2018-12-26 | BIOTECHNOLOGY VALUE FUND L P | VBI Vaccines Inc/BC | 2,408,786 | 2.5% | EDGAR |
| SC 13D/A | 2018-12-17 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 25,700,263 | 27.6% | EDGAR |
| SC 13G/A | 2018-02-13 | Honig Barry C | VBI Vaccines Inc/BC | 1,549,609 | 2.4% | EDGAR |
| SC 13D/A | 2017-11-02 | ARCH VENTURE FUND VI LP | VBI Vaccines Inc/BC | - | - | EDGAR |
| SC 13D/A | 2017-11-01 | Opko Health, Inc. | VBI Vaccines Inc/BC | 6,678,752 | 16.6% | EDGAR |
| SC 13D/A | 2017-10-30 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 11,414,549 | 17.9% | EDGAR |
| SC 13G/A | 2017-02-13 | Honig Barry C | VBI Vaccines Inc/BC | 3,477,371 | 9.6% | EDGAR |
| SC 13D | 2016-06-27 | ARCH VENTURE FUND VI LP | VBI Vaccines Inc/BC | 2,713,092 | 7.5% | EDGAR |
| SC 13G | 2016-02-23 | Brauser Michael | SciVac Therapeutics Inc. | 61,183,738 | 8.1% | EDGAR |
| SC 13G/A | 2016-02-02 | Honig Barry C | SciVac Therapeutics Inc. | 74,251,080 | 9.8% | EDGAR |
| SC 13G | 2015-12-02 | Honig Barry C | SciVac Therapeutics Inc. | 72,870,480 | 9.6% | EDGAR |
| SC 13G | 2014-11-06 | LEVON RESOURCES LTD. | Pershing Gold Corp. | 35,178,572 | 10.0% | EDGAR |